In the last three months, 21 analysts have published ratings on Boston Scientific (NYSE:BSX), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 12 | 8 | 1 | 0 | 0 |
| Last 30D | 1 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 1 | 0 | 0 | 0 |
| 2M Ago | 3 | 0 | 0 | 0 | 0 |
| 3M Ago | 6 | 6 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $84.62, a high estimate of $95.00, and a low estimate of $73.00. Surpassing the previous average price target of $76.95, the current average has increased by 9.97%.
Analyzing Analyst Ratings: A Detailed Breakdown
The analysis of recent analyst actions sheds...
Login or create a forever free account to read this news
Sign up/Log in